Treating a cancerous tumor is like watering a houseplant with a fire hose—too much water kills the plant, just as too much chemotherapy and radiation kills the patient before it kills the tumor.
However, if the gastrointestinal tract remains healthy and functioning, the chances of survival increase exponentially, said Jian-Guo Geng, associate professor at the University of Michigan School of Dentistry. Recently, Geng’s lab discovered a biological mechanism that preserves the gastrointestinal tracts in mice who were delivered lethal doses of chemotherapy.
The findings, which will appear in the journal Nature, could revolutionize cancer therapy, Geng said. He emphasized that this had not yet been tested in humans, and right now there’s no way to know if people will respond similarly.
“All tumors from different tissues and organs can be killed by high doses of chemotherapy and radiation, but the current challenge for treating the later-staged metastasized cancer is that you actually kill the host before you kill the tumor.
“It’s our belief that this could eventually cure later-staged metastasized cancer. People will not die from cancer, if our prediction is true,” said Geng. “We cannot know this yet, but in mice it has shown promise. Years down the road, we may have a way to make humans tolerate lethal doses of chemotherapy and radiotherapy. In this way, the later-staged, metastasized cancer can be eradicated by increased doses of chemotherapy and radiation.”
Geng’s lab found that when certain proteins bind with a specific molecule on intestinal stem cells, it revs intestinal stem cells into overdrive for intestinal regeneration and repair in mice. Stem cells naturally heal damaged organs and tissues, but so-called “normal” amounts of stem cells in the intestine simply cannot keep up with the wreckage left behind by the lethal doses of chemotherapy and radiation required to successfully treat late-stage tumors.
However, the phalanx of extra stem cells protect the intestine and gastrointestinal tract, which allows the ingestion of nutrients so the body can perform other critical functions and the bacterial toxins in the intestine are prevented from entering the blood circulation, Geng said.
In the future, if the findings are tested in humans and show promise, these factors could give human cancer patients just enough of an extra edge to survive the stronger doses of chemotherapy and radiation, until the tumor or tumors are eradicated.
Geng stressed that even if the findings do show promise in humans, it could take a decade or longer before an application becomes available to use on people.
In the study, 50-to-75 percent of the mice treated with the molecule survived otherwise lethal doses of chemotherapy. All of the mice that did not receive the molecule died, Geng said.
The Latest on: Cancer therapy
- Angelina Jolie Has a 'Very Moving' Experience at French Cancer Research Centeron October 20, 2019 at 9:48 am
“It was a very moving, very human experience to see doctors from around the world coming together every day trying to find solutions to cancer, working alongside the very patients — some of them young ...
- Parents of kids with cancer speak up about cancer drug shortageon October 20, 2019 at 9:11 am
The United States is facing a shortage of a critical drug used to treat children with cancer. As parents worry they won't be able to get the life-saving treatment for their children, doctors say the ...
- Dr. Bernard Fisher, Who Revolutionized Breast Cancer Treatment, Dies at 101on October 19, 2019 at 3:26 pm
Among the three groups there was no difference in cancer recurrence, metastasis to distant parts of the body or death rates. By 1979, simple mastectomy had become the standard treatment for breast ...
- How Has Pension Legislation Affected NHS Breast Cancer Treatment Wait Times? Some Odd News From The UKon October 19, 2019 at 5:02 am
on June 6,2019 in London,England. (Photo by Peter Dazeley/Getty Images) Here’s a headline one doesn’t see every day: “Pensions crisis blamed for trust’s worst-ever breast cancer waits.” That’s from ...
- Potential for Fundamental Change in the Treatment of Brain Canceron October 18, 2019 at 5:33 pm
Noxopharm commences a research program pursuing a novel approach to the treatment of glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer Based on recent international ...
- How proton therapy can treat breast canceron October 18, 2019 at 8:29 am
Breast cancer survivor Sharon Prolow of Jupiter and Dr. Marcio Fagundes of the Miami Cancer Institute explain how proton therapy can treat breast cancer.
- Clinical Challenges: Sequencing in Second-Line Therapy in HR-positive Breast Canceron October 18, 2019 at 8:08 am
"Now that we have survival data for several CDK4/6 inhibitors in the upfront setting with endocrine therapy, the biggest clinical question remains what to do after that," said Jane L. Meisel, MD, of ...
- Cervical Cancer Treatment Market Analysis, Size, Company Profiles, and Insights Covering Market Share: Forecast 2018 to 2026on October 18, 2019 at 6:09 am
Oct 18, 2019 (Market Prediction via COMTEX) -- According to ARC’s latest market research report, The global Cervical Cancer Treatment Market worth $11.2 billion by 2026 and growing CAGR around 6.5 % ...
- Breast Cancer Treatment Market Revenue and Value Chain 2020-2029on October 18, 2019 at 5:37 am
Oct 18, 2019 (WiredRelease via COMTEX) -- Breast Cancer Treatment Market by Growth 2020 – Technological Strategies, Business Advancements and Top-Vendor Landscape 2029″, anticipated to grow with the ...
- The Health 202: Cancer patients have steep expenses beyond treatment. This rock band is trying to help.on October 18, 2019 at 5:18 am
Cancer patients may have to quit their job while undergoing treatment. They may have to travel out of state to see specialists. They may have to follow a special, more expensive diet. The burdens can ...
via Google News and Bing News